MA26531A1 - PHARMACEUTICAL COMPOSITION - Google Patents
PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- MA26531A1 MA26531A1 MA25211A MA25211A MA26531A1 MA 26531 A1 MA26531 A1 MA 26531A1 MA 25211 A MA25211 A MA 25211A MA 25211 A MA25211 A MA 25211A MA 26531 A1 MA26531 A1 MA 26531A1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9717428.8A GB9717428D0 (en) | 1997-08-19 | 1997-08-19 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26531A1 true MA26531A1 (en) | 2004-12-20 |
Family
ID=10817619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25211A MA26531A1 (en) | 1997-08-19 | 1998-08-12 | PHARMACEUTICAL COMPOSITION |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1007010A2 (en) |
| JP (1) | JP2002511101A (en) |
| KR (1) | KR20010014080A (en) |
| CN (1) | CN1263461A (en) |
| AR (1) | AR016629A1 (en) |
| AU (1) | AU9343098A (en) |
| BR (1) | BR9810458A (en) |
| CA (1) | CA2295016A1 (en) |
| CO (1) | CO4960657A1 (en) |
| GB (1) | GB9717428D0 (en) |
| MA (1) | MA26531A1 (en) |
| PE (1) | PE105699A1 (en) |
| TR (1) | TR199903209T2 (en) |
| WO (1) | WO1999008666A2 (en) |
| ZA (1) | ZA987392B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS6633A (en) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Compositions of finasteride tablets |
| JP4880461B2 (en) | 2003-08-13 | 2012-02-22 | バイオコン・リミテッド | Microparticulate fatty acid salt solid formulation for therapeutics |
| JP2007517788A (en) * | 2004-01-02 | 2007-07-05 | ファルマコン・フォルシュング・ウント・ベラートゥング・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Process for producing 1,2-unsaturated azasteroids |
| WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
| WO2010117873A2 (en) | 2009-04-06 | 2010-10-14 | Banner Pharmacaps, Inc. | Progesterone solutions for increased bioavailability |
| ES2385240B1 (en) | 2010-07-26 | 2013-09-23 | Gp-Pharm, S.A. | CAPSULES OF ACTIVE PHARMACEUTICAL PRINCIPLES AND POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF PROSTATE DISEASES. |
| US8900631B2 (en) | 2011-04-28 | 2014-12-02 | Health Science Funding, LLC | Dosage form to increase prasterone bioavailability |
| CN103169712B (en) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | Improve dutasteride's preparation of bioavilability and preparation method thereof |
| WO2014002015A1 (en) | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
| ES2555485T1 (en) | 2014-05-26 | 2016-01-04 | Galenicum Health S.L. | Pharmaceutical compositions containing an active agent |
| KR101679992B1 (en) * | 2015-12-31 | 2016-11-28 | 주식회사 유유제약 | Pharmaceutical composition comprising dutasteride and propylene glycol monolaurate and preparation method of the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
| DE3607651A1 (en) * | 1986-03-06 | 1987-09-10 | Schering Ag | COMBINATION OF AROMATASE INHIBITORS AND TESTOSTERONE-5 (ALPHA) REDUCTASE INHIBITORS |
| TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
| TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
-
1997
- 1997-08-19 GB GBGB9717428.8A patent/GB9717428D0/en active Pending
-
1998
- 1998-08-12 MA MA25211A patent/MA26531A1/en unknown
- 1998-08-14 AR ARP980104050A patent/AR016629A1/en unknown
- 1998-08-14 PE PE1998000735A patent/PE105699A1/en not_active Application Discontinuation
- 1998-08-17 KR KR19997012116A patent/KR20010014080A/en not_active Application Discontinuation
- 1998-08-17 BR BR9810458-6A patent/BR9810458A/en not_active Application Discontinuation
- 1998-08-17 JP JP51280899A patent/JP2002511101A/en active Pending
- 1998-08-17 WO PCT/EP1998/005194 patent/WO1999008666A2/en not_active Application Discontinuation
- 1998-08-17 EP EP98946351A patent/EP1007010A2/en not_active Withdrawn
- 1998-08-17 CN CN98806380A patent/CN1263461A/en active Pending
- 1998-08-17 TR TR1999/03209T patent/TR199903209T2/en unknown
- 1998-08-17 CA CA002295016A patent/CA2295016A1/en not_active Abandoned
- 1998-08-17 AU AU93430/98A patent/AU9343098A/en not_active Abandoned
- 1998-08-17 ZA ZA9807392A patent/ZA987392B/en unknown
- 1998-08-18 CO CO98047010A patent/CO4960657A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2295016A1 (en) | 1999-02-25 |
| TR199903209T2 (en) | 2000-05-22 |
| AU9343098A (en) | 1999-03-08 |
| WO1999008666A3 (en) | 1999-04-15 |
| WO1999008666A2 (en) | 1999-02-25 |
| CO4960657A1 (en) | 2000-09-25 |
| EP1007010A2 (en) | 2000-06-14 |
| AR016629A1 (en) | 2001-07-25 |
| GB9717428D0 (en) | 1997-10-22 |
| PE105699A1 (en) | 1999-11-25 |
| JP2002511101A (en) | 2002-04-09 |
| BR9810458A (en) | 2000-09-05 |
| CN1263461A (en) | 2000-08-16 |
| KR20010014080A (en) | 2001-02-26 |
| ZA987392B (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID22891A (en) | PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALANOL-DECONGESTANT COMBINATIONS | |
| NO962606D0 (en) | Pharmaceutical composition | |
| DZ2516A1 (en) | Aerosol pharmaceutical composition. | |
| ID24654A (en) | OMEPRAZOLA PHARMACEUTICAL FORMULATION | |
| FI955311A (en) | Pharmaceutical composition base | |
| NO980546D0 (en) | Pharmaceutical agents | |
| FR2751540B1 (en) | ANTITHROMBOTIC PHARMACEUTICAL COMPOSITION | |
| IS5331A (en) | New pharmaceutical mix | |
| MA26531A1 (en) | PHARMACEUTICAL COMPOSITION | |
| ID29294A (en) | PHARMACEUTICAL COMPOSITION | |
| BR9507768A (en) | Pharmaceutical composition | |
| LV11727A (en) | Pharmaceutical composition | |
| FI973229A0 (en) | New pharmaceutical composition | |
| ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
| ID18698A (en) | PHARMACEUTICAL COMPOSITION | |
| FI973280A (en) | Pharmaceutical composition | |
| ITMI962628A0 (en) | PHARMACEUTICAL COMPOSITION | |
| BR9605777A (en) | Pharmaceutical composition | |
| ID23531A (en) | PHARMACEUTICAL COMPOSITION | |
| NO964309D0 (en) | Pharmaceutical composition | |
| IT1272935B (en) | PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN | |
| SE9402924D0 (en) | Novel pharmaceutical composition | |
| BR1100755A (en) | pharmaceutical composition | |
| BR1101151A (en) | Pharmaceutical compounds and composition | |
| SE9402437D0 (en) | Pharmaceutical composition |